Syngene International Ltd.
BSE: 539268 | Sector: Health care |
NSE: SYNGENE | ISIN Code: INE398R01022 |
BSE 00:00 | 05 Mar | 544.60 |
-7.70 (-1.39%) |
OPEN
552.35 |
HIGH
553.45 |
LOW
540.50 |
NSE 00:00 | 05 Mar | 544.30 |
-7.55 (-1.37%) |
OPEN
554.65 |
HIGH
554.80 |
LOW
541.70 |
OPEN | 552.35 |
PREVIOUS CLOSE | 552.30 |
VOLUME | 33597 |
52-Week high | 644.65 |
52-Week low | 201.65 |
P/E | 59.98 |
Mkt Cap.(Rs cr) | 21,784 |
Buy Price | 544.60 |
Buy Qty | 50.00 |
Sell Price | 545.50 |
Sell Qty | 1.00 |
Syngene International Ltd. (SYNGENE) - Latest News & Headlines
-
Pharma shares gain; Natco, Glenmark, Syngene, Sequent Scientific up over 5%
11.44 am | 7 Dec 2020 | Business Standard
Patient footfalls are gaining traction in healthcare units as demand from non-Covid-19 patients is gathering pace, according to a November 25 report b...
-
Syngene: Investors with long term view should look at the stock on dips
1.17 am | 25 Sep 2020 | Business Standard
While Covid-19 could is a near term opportunity, contract manufacturing is the key medium-term trigger
-
Syngene Int'l hits record high in a weak market, rallies 26% in two weeks
10.46 am | 24 Sep 2020 | Business Standard
The stock rallied 6.5 per cent to Rs 596.85, surpassing its previous high Rs 594.75, touched on September 15, 2020, on the BSE.
-
Syngene International surges 9% on ICMR nod for its Covid-19 test kit
11.54 am | 10 Sep 2020 | Business Standard
The product will be launched once it receives approval from the Central Drugs Standard Control Organisation (CDSCO) next.
-
Syngene-HiMedia's Elisa test kit for Covid-19 gets ICMR approval
8.11 pm | 9 Sep 2020 | Business Standard
The product will be launched once it receives approval from the Central Drugs Standard Control Organisation next
Quick Links for Syngene International:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices